# Anhui Iprocom Biotechnology

**Canonical:** https://apis.io/providers/anhui-iprocom-biotechnology/  
**Website:** https://www.nasdaqprivatemarket.com/  
**APIs profiled:** 0

Anhui Iprocom Biotechnology is a biotechnology company based in Anhui, China. It focuses on research and development of biopharmaceutical products and related technologies. The company is listed in secondary-market harvests and is being profiled for API Evangelist documentation. Further public information about its services, products, and API offerings is limited at this time. No additional public website or detailed API documentation could be located through standard web searches, indicating a low public exposure of its developer resources.

## Kin Score — 3.4 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 3.4).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Anhui Iprocom Biotechnology Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, China, Research, Biopharma, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/anhui-iprocom-biotechnology/). Scores are computed from the provider's own public artifacts under a published rubric.
